Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

Share Price is delayed by 15 minutes
Get Live Data
20.50    0.50 (2.50%)
Bid:
20.00
Ask:
21.00
Spread: 1.00 (5.00%)
Market Cap: £14.99m
ALT Live PriceLast checked at - London Stock Exchange

Intraday Altitude Group Share Chart

Trading Update & Secured Credit Facility

31 Mar 2022 07:00

RNS Number : 6785G
Altitude Group PLC
31 March 2022
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

Altitude Group plc

("Altitude", the "Company" or the "Group")

Full Year Trading Update & Secured Credit Facility

 

Altitude Group plc (AIM: ALT), the operator of the leading marketplace for the global promotional products industry, provides a trading update for the financial year to 31 March 2022 ("FY2022"). The Board is pleased to report that the Group is experiencing accelerated recovery post Covid and continues to successfully navigate the current business climate. The Group has increased its core business revenue, replacing the £1.9m FY2021 of one-off Personal Protective Equipment sales. With strong trading in FY2022, and key financial metrics tracking ahead of last year, the Group expects to report FY2022 revenue of c. £12.0m (FY2021:£7.7m) and adjusted operating profit * of c. £1.0m (FY2021: £0.6m), representing increases of c. 56% and c. 80% respectively.

 

*Operating profit before share-based payment charges, amortisation of intangible assets, depreciation of tangible assets and exceptional charges

Services

Group services revenue, which is derived from both AIM members and contracted Preferred Partners, grew in FY2022 by an estimated 20%, from successful delivery of AIM network performance. Approximately 93% of services revenues are either annual recurring fixed revenues or repeating ad valorem marketing revenues based on AIM members transactional volume with contracted Preferred Partners.

Merchanting

Our merchanting programmes, which includes AIM Capital Solutions (ACS) acting as principal in the underlying transaction, grew substantially through the period with revenue of c. £5.6m in FY2022 (£2.3m FY2021). We are pleased with the platform that has been built to support our Merchanting programmes and are poised for continued growth.

Balance Sheet and Cash

The Group's cash balances and working capital cycle followed the normal and expected path with working capital requirement reducing in Q1 22. At 31 March 2022, the Group is expecting to report net cash excluding IFRS 16 lease liabilities of at least £1m.

 

New Bank Credit Facility

The Group is also pleased to report it has secured a new working capital credit facility (the "Facility") with TD Bank N.A., with an initial 12 month revolving facility of $700k. The Facility has no significant financial covenants and is secured by the assets of the US Group with a parental guarantee from Altitude. The Facility will provide access to non-dilutive funding to support the Group in executing its growth strategy. The Facility has an arrangement fee of $3,500 annually and incurs interest at 1% above the US Prime Rate on drawdown. This Facility is expected to remain undrawn at the year end.

Nichole Stella, Group CEO of Altitude, said:

"We have emerged in the post-pandemic era with positive momentum. Throughout this difficult period we have shown consistent and organic revenue growth and we have not needed to raise any forms of finance, neither equity or debt. It is testament to the resilience and hard work of our team, our strong supplier relationships and our market leading customer proposition, that we are able to report such a positive statement. As such, we are focused on our strategy to scale the business and are well placed for accelerated future growth."

 

Altitude Group plc

Nichole Stella, Chief Executive Officer

Graham Feltham, Chief Financial Officer

 

Via Zeus Capital

Zeus (Nominated Adviser & Broker)

Dan Bate (Investment Banking)

David Foreman (Investment Banking)

James Edis (Investment Banking)

Dominic King (Corporate Broking)

Tel: +44 (0) 203 829 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTWPUMUWUPPPUU
Date   Source Headline
8th Jun 20267:00 amRNSDirector/PDMR Shareholding
1st Jun 20268:31 amRNSExercise & Grant of Options and TVR
17th Apr 20267:00 amRNSBoard Role Change
14th Apr 20263:25 pmRNSDirector/PDMR Dealing
9th Apr 202612:00 pmRNSDirector/PDMR Dealing
31st Mar 20267:00 amRNSTrading Update
5th Mar 20263:39 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSAppointment of Independent Non-Executive Director
10th Feb 202612:32 pmRNS-RAppointment of Chief Commercial Officer
4th Feb 20267:00 amRNSAppointment of Nominated Adviser and Sole Broker
19th Jan 20261:33 pmRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
1st Dec 20259:01 amRNSPDMR Dealing
28th Nov 20257:00 amRNSChange of Registered Office
27th Nov 20254:57 pmRNSCorrection: Exercise & Grant of Options and TVR
27th Nov 20257:30 amRNSExercise & Grant of Options, PDMR Dealings and TVR
27th Nov 20257:00 amRNSInterim Results
11th Nov 20257:00 amRNSTrading Update, Board Change and Notice of Results
30th Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20257:00 amRNSResult of AGM
12th Sep 20257:00 amRNSDirector/PDMR Dealing
11th Sep 20257:00 amRNSDirector/PDMR Dealing
10th Sep 20257:00 amRNSDirector/PDMR Dealing
8th Sep 20257:00 amRNSDirector/PDMR Dealing
5th Sep 20257:00 amRNSDirector/PDMR Dealing
15th Aug 20254:20 pmRNSChange of Venue for the 2025 AGM
7th Aug 20257:00 amRNSAudited Annual Results and Notice of AGM
30th Jul 20257:00 amRNSNotice of Results
15th Jul 20257:00 amRNSBoard Changes and Trading Update
23rd Jun 20257:00 amRNSAppointment of CFO
17th Jun 20257:00 amRNSBoard Change and Trading Update
15th May 20257:00 amRNSGrant of Options and PDMR Dealings
9th May 20255:50 pmRNSDirector/PDMR Dealing
9th Apr 20257:00 amRNSExercise of Options, Director Dealings and TVR
1st Apr 20257:00 amRNSDirector/PDMR Dealing
31st Mar 20257:00 amRNSTrading Update and New University Contract Awards
28th Mar 20257:00 amRNSChange of Registered Office
11th Mar 20257:00 amRNSDirector/PDMR Dealings
6th Mar 20257:00 amRNSDirectorate Change
3rd Dec 20247:00 amRNSInterim Results
15th Nov 20247:00 amRNSTrading Update and Notice of Results
8th Oct 20244:04 pmRNSHolding(s) in Company
23rd Sep 20244:47 pmRNSResult of AGM
6th Sep 202412:30 pmRNSPosting of Annual Report and Notice of AGM
30th Jul 20247:00 amRNSAudited Annual Results and Notice of AGM
23rd Jul 20247:00 amRNSFull Year Trading Update
3rd Jun 20249:28 amRNSExercise of Options, Director Dealings and TVR
20th May 20247:00 amRNSGrant of Options and PDMR Dealings
1st May 20247:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.